Literature DB >> 21511184

Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.

Samuel Huber1, Nicola Gagliani, Enric Esplugues, William O'Connor, Francis J Huber, Ashutosh Chaudhry, Masahito Kamanaka, Yasushi Kobayashi, Carmen J Booth, Alexander Y Rudensky, Maria Grazia Roncarolo, Manuela Battaglia, Richard A Flavell.   

Abstract

T helper 17 (Th17) cells are important for host defense against extracellular microorganisms. However, they are also implicated in autoimmune and chronic inflammatory diseases, and as such need to be tightly regulated. The mechanisms that directly control committed pathogenic Th17 cells in vivo remain unclear. We showed here that IL-17A-producing CD4+ T cells expressed interleukin-10 receptor α (IL-10Rα) in vivo. Importantly, T cell-specific blockade of IL-10 signaling led to a selective increase of IL-17A+IFN-γ⁻ (Th17) and IL-17A+IFN-γ+ (Th17+Th1) CD4+ T cells during intestinal inflammation in the small intestine. CD4+Foxp3IL-10-producing (Tr1) cells and CD4+Foxp3+ regulatory (Treg) cells were able to control Th17 and Th17+Th1 cells in an IL-10-dependent manner in vivo. Lastly, IL-10 treatment of mice with established colitis decreased Th17 and Th17+Th1 cell frequencies via direct signaling in T cells. Thus, IL-10 signaling directly suppresses Th17 and Th17+Th1 cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21511184      PMCID: PMC3113617          DOI: 10.1016/j.immuni.2011.01.020

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  49 in total

1.  IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function.

Authors:  L Ding; E M Shevach
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

2.  Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

3.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy.

Authors:  Pengfei Zhou; Cathy Streutker; Rajka Borojevic; Yufa Wang; Ken Croitoru
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-09       Impact factor: 4.052

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.

Authors:  Atsuhiro Ogawa; Akira Andoh; Yoshio Araki; Tadao Bamba; Yoshihide Fujiyama
Journal:  Clin Immunol       Date:  2004-01       Impact factor: 3.969

7.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

8.  A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Authors:  H Groux; A O'Garra; M Bigler; M Rouleau; S Antonenko; J E de Vries; M G Roncarolo
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

9.  Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.

Authors:  Masahito Kamanaka; Samuel Huber; Lauren A Zenewicz; Nicola Gagliani; Chozhavendan Rathinam; William O'Connor; Yisong Y Wan; Susumu Nakae; Yoichiro Iwakura; Liming Hao; Richard A Flavell
Journal:  J Exp Med       Date:  2011-04-25       Impact factor: 14.307

10.  The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor.

Authors:  S D Spencer; F Di Marco; J Hooley; S Pitts-Meek; M Bauer; A M Ryan; B Sordat; V C Gibbs; M Aguet
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

View more
  268 in total

1.  Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis.

Authors:  Kirsten A Kulcsar; Victoria K Baxter; Ivorlyne P Greene; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

2.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

3.  The Intestine: where amazing things happen.

Authors:  Nicola Gagliani; Samuel Huber; Richard A Flavell
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

Review 4.  Immunoregulation by the gut microbiota.

Authors:  Junko Nishio; Kenya Honda
Journal:  Cell Mol Life Sci       Date:  2012-04-22       Impact factor: 9.261

Review 5.  Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Authors:  Megan E Himmel; Yu Yao; Paul C Orban; Theodore S Steiner; Megan K Levings
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

6.  A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation.

Authors:  Rahul Sharma; Sun-Sang J Sung; Felicia Gaskin; Shu Man Fu; Shyr-Te Ju
Journal:  J Autoimmun       Date:  2012-03-29       Impact factor: 7.094

Review 7.  Highlights of 10 years of immunology in Nature Reviews Immunology.

Authors:  Ruslan Medzhitov; Ethan M Shevach; Giorgio Trinchieri; Andrew L Mellor; David H Munn; Siamon Gordon; Peter Libby; Göran K Hansson; Ken Shortman; Chen Dong; Dmitry Gabrilovich; Leona Gabryšová; Ashleigh Howes; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

Review 8.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.

Authors:  C Andrew Stewart; Hannah Metheny; Noriho Iida; Loretta Smith; Miranda Hanson; Folkert Steinhagen; Robert M Leighty; Axel Roers; Christopher L Karp; Werner Müller; Giorgio Trinchieri
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

10.  Interleukin-10 (IL-10) inhibits Borrelia burgdorferi-induced IL-17 production and attenuates IL-17-mediated Lyme arthritis.

Authors:  Emily S Hansen; Velinka Medić; Joseph Kuo; Thomas F Warner; Ronald F Schell; Dean T Nardelli
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.